Molecular Partners
MOLN
#5971
Rank
$0.21 B
Marketcap
$7.03
Share price
4.93%
Change (1 day)
-63.58%
Change (1 year)

P/E ratio for Molecular Partners (MOLN)

P/E ratio as of October 2022 (TTM): 2.03

According to Molecular Partners's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 2.02536. At the end of 2021 the company had a P/E ratio of -8.53.

P/E ratio history for Molecular Partners from 2022 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-8.53

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.